What is the address of DR. BELAID?

The registered office of DR. BELAID is located at Groot-Bijgaardenstraat 14, 1082 Sint-Agatha-Berchem.

Is DR. BELAID still active?

Yes. According to the CBE (2 November 2026) DR. BELAID is active, legal situation “Normale toestand”, started on 19 May 2021.

Is DR. BELAID registered on Peppol?

Yes, DR. BELAID is registered on the Peppol network with ID 0208:0768551289.

What is the enterprise number of DR. BELAID?

The enterprise number of DR. BELAID is BE0768551289.

When was DR. BELAID founded?

DR. BELAID was founded on 19 May 2021.

Who are the directors of DR. BELAID?

According to the 2025 annual accounts, the directors of DR. BELAID are: Aïmen Belaïd.

Is DR. BELAID a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 May 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. BELAID make in 2025?

DR. BELAID posted a profit after taxes of € 114,378 in financial year 2025.

What is the revenue of DR. BELAID?

As a small company, DR. BELAID is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 168,125.

DR. BELAID (Private Limited) - Sint-Agatha-Berchem

Dossier DR. BELAID, printed on 2 November 2026 from databakkes.be/en/0768551289/dr-belaid. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 34 % of short-term debt in 2025; threshold 65 %.
Busy address KBO

28 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

DR. BELAID from Sint-Agatha-Berchem, company number BE0768551289, closed financial year 2025 with a result of € 114,378 after tax. For that financial year DR. BELAID recorded a gross margin of € 168,125 and equity of € 223,204. Compared with financial year 2024, the result moved from € 110,087 to € 114,378. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.

What it is worth Healthy

€ 223,204

▼ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 114,378

▲ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 47,308

▼ 13% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 150,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 20,171

▼ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 104,974

▲ 9% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 184,507 Gross margin 2022: € 184,507 First fiscal year in the series	€ 170,277 Gross margin 2023: € 170,277 ▼ 8% vs 2022 (€ 184,507) Unfavourable step	€ 150,846 Gross margin 2024: € 150,846 ▼ 11% vs 2023 (€ 170,277) Unfavourable step	€ 168,125 Gross margin 2025: € 168,125 ▲ 11% vs 2024 (€ 150,846) Favourable step	▲ 11%
Profit after taxes	€ 127,370 Profit after taxes 2022: € 127,370 First fiscal year in the series	€ 118,370 Profit after taxes 2023: € 118,370 ▼ 7% vs 2022 (€ 127,370) Unfavourable step	€ 110,087 Profit after taxes 2024: € 110,087 ▼ 7% vs 2023 (€ 118,370) Unfavourable step	€ 114,378 Profit after taxes 2025: € 114,378 ▲ 4% vs 2024 (€ 110,087) Favourable step	▲ 4%
Equity	€ 130,370 Equity 2022: € 130,370 First fiscal year in the series	€ 248,739 Equity 2023: € 248,739 ▲ 91% vs 2022 (€ 130,370) Favourable step	€ 258,826 Equity 2024: € 258,826 ▲ 4% vs 2023 (€ 248,739) Favourable step	€ 223,204 Equity 2025: € 223,204 ▼ 14% vs 2024 (€ 258,826) Unfavourable step	▼ 14%
Total debts	€ 75,243 Total debts 2022: € 75,243 First fiscal year in the series	€ 92,463 Total debts 2023: € 92,463 ▲ 23% vs 2022 (€ 75,243) Unfavourable step	€ 217,420 Total debts 2024: € 217,420 ▲ 135% vs 2023 (€ 92,463) Unfavourable step	€ 275,145 Total debts 2025: € 275,145 ▲ 27% vs 2024 (€ 217,420) Unfavourable step	▲ 27%
Cash	€ 13,014 Cash 2022: € 13,014 First fiscal year in the series	€ 32,943 Cash 2023: € 32,943 ▲ 153% vs 2022 (€ 13,014) Favourable step	€ 54,096 Cash 2024: € 54,096 ▲ 64% vs 2023 (€ 32,943) Favourable step	€ 47,308 Cash 2025: € 47,308 ▼ 13% vs 2024 (€ 54,096) Unfavourable step	▼ 13%
Retained profit	€ 127,370 Retained profit 2022: € 127,370 First fiscal year in the series	€ 245,739 Retained profit 2023: € 245,739 ▲ 93% vs 2022 (€ 127,370) Favourable step	€ 255,826 Retained profit 2024: € 255,826 ▲ 4% vs 2023 (€ 245,739) Favourable step	€ 220,204 Retained profit 2025: € 220,204 ▼ 14% vs 2024 (€ 255,826) Unfavourable step	▼ 14%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 100,000 Dividend 2024: € 100,000 Unchanged (€ 0) Unchanged	€ 150,000 Dividend 2025: € 150,000 ▲ 50% vs 2024 (€ 100,000) Unchanged	▲ 50%
Bank debt	€ 23,427 Bank debt 2022: € 23,427 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 23,427) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 205,613 Balance sheet total 2022: € 205,613 First fiscal year in the series	€ 341,203 Balance sheet total 2023: € 341,203 ▲ 66% vs 2022 (€ 205,613) Unchanged	€ 476,247 Balance sheet total 2024: € 476,247 ▲ 40% vs 2023 (€ 341,203) Unchanged	€ 498,349 Balance sheet total 2025: € 498,349 ▲ 5% vs 2024 (€ 476,247) Unchanged	▲ 5%

Key figures of DR. BELAID, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. BELAID?

What happened at DR. BELAID in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 30, 2026 New annual accounts for financial year 2025: profit of € 114,378 (▲ 4% vs 2024). filed late Source: NBB ↗
May 19, 2021 New establishment in Tubize. KBO
2021 Aïmen Belaïd became a director. NBB
May 19, 2021 Start of the company according to the CBE. KBO

In short

From € 127,370 profit in 2022 to € 114,378 profit in 2025.

Paid € 135,895 in corporate taxes since 2022.

Best year ever: 2022, with € 127,370 profit.

Paid out € 250,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Aïmen Belaïd

DR. BELAID

Behind DR. BELAID is Aïmen Belaïd.

Directors

According to the 2025 annual accounts

Aïmen Belaïd

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Groot-Bijgaardenstraat 14

1082 Sint-Agatha-Berchem

2.325.531.745

Rue de Stierbecq 17

1480 Tubize

Active since 19 May 2021

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 28 companies are registered at this address.

All companies at this address →

Huis Alfons Simkens

€ 53,656 gross margin · 2024

SCALP RECORDS

€ -440 gross margin · 2025

Infoma

€ -8,571 gross margin · 2023

STAES FINANCIEEL MANAGEMENT

T. & C.C. INVEST

€ 4,351 gross margin · 2023

+23 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0768.551.289
VAT number: BE 0768.551.289
Registered office: Groot-Bijgaardenstraat 14, 1082 Sint-Agatha-Berchem
Names & denominations: DR. BELAID
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 19 May 2021
Peppol: Active · Active since 11 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗